leadf
logo-loader
viewLobe Sciences Ltd

Lobe Sciences: Find out more about the company advancing transformational treatments for brain injuries

Hear from executives at Lobe Sciences and Silo Pharma at Proactive's psychedelic-themed virtual showcase event on Tuesday February 23

Lobe Sciences Ltd -

Lobe Sciences Ltd (CSE:LOBE) (OTCMKTS: (GTSIF) is joining Silo Pharma Inc (OTCMKTS:SILO) to present at Proactive’s next virtual showcase event on February 23.

The psychedelic-themed event will be hosted by Proactive’s Christine Corrado and kicks off on Tuesday at 1 PM ET.

SIGN-UP: Proactive One2One February 23

Lobe Sciences is mastering the development of transformational medicines and devices as it builds a growing portfolio of intellectual property to support wellness and improve mental health.

The Vancouver-based company is currently advancing unique medicines and devices to treat mild traumatic brain injury and post-traumatic stress disorder, as well as other indications. With five provisional patents, a pre-clinical study underway and a drug delivery device in engineering development, Lobe is quickly making a name for itself in the world of psychedelics.

In December, Lobe sold its cannabis asset Cowlitz County Cannabis Cultivation to Ionic Brands, netting $23 million and a stake in the latter company to keep a foothold in the red-hot US cannabis space.

CEO Phil Young will share the company’s plans for the proceeds and other strategic initiatives on its plate for 2021 with participants on Tuesday.

CLICK HERE TO REGISTER

Quick facts: Lobe Sciences Ltd

Price: 0.21 CAD

CSE:LOBE
Market: CSE
Market Cap: $34.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lobe Sciences Ltd named herein, including the promotion by the Company of Lobe Sciences Ltd in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Lobe Sciences Ltd presents at Proactive's One2One virtual investor forum

Lobe Sciences Ltd (CSE:LOBE) (OTCMKTS:GTSIF) CEO Philip Young presents at Proactive's One2One virtual investor forum. The Vancouver-based company is currently advancing unique medicines and devices to treat mild traumatic brain injury and post-traumatic stress disorder, as well as other...

1 day, 22 hours ago

2 min read